Home/Filings/4/0000950170-24-082416
4//SEC Filing

Dunn Edmund 4

Accession 0000950170-24-082416

CIK 0001826457other

Filed

Jul 8, 8:00 PM ET

Accepted

Jul 9, 4:15 PM ET

Size

5.3 KB

Accession

0000950170-24-082416

Insider Transaction Report

Form 4
Period: 2024-07-05
Dunn Edmund
Principal Accounting Officer
Transactions
  • Sale

    Common Stock

    2024-07-05$3.83/sh1,610$6,16613,944 total
Footnotes (2)
  • [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.83 to $3.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file

Issuer

Monte Rosa Therapeutics, Inc.

CIK 0001826457

Entity typeother

Related Parties

1
  • filerCIK 0001989401

Filing Metadata

Form type
4
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:15 PM ET
Size
5.3 KB